Peter Heerma
Corporate Officer/Principal at TRAVERE THERAPEUTICS, INC.
Net worth: 536 321 $ as of 29/04/2024
Profile
Peter Heerma is currently the Chief Commercial Officer at Travere Therapeutics, Inc. Prior to this, he worked as the Director of Commercial Strategy Renal Care at Abbott Laboratories from 2003 to 2012, Senior Director of Portfolio Strategy at AbbVie, Inc. from 2012 to 2015, and General Manager of Oncology & Cardiovascular Products at Amgen, Inc. from 2015 to 2019.
He received his graduate degree from the University of Lund in 1997 and his undergraduate degree from Stenden University in 1996.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/01/2024 | 99,503 ( 0.13% ) | 536 321 $ | 29/04/2024 |
Peter Heerma active positions
| Companies | Position | Start |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | 30/09/2019 |
Former positions of Peter Heerma
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 31/08/2019 |
| ABBVIE INC. | Corporate Officer/Principal | 31/10/2015 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 31/10/2012 |
Training of Peter Heerma
| University of Lund | Graduate Degree |
| Stenden University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
- Stock Market
- Insiders
- Peter Heerma
